Clinical trial
Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
NCT00108706 · City Hospitals Sunderland NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00108706 |
|---|---|
| Title | Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) |
| Official title | Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) |
| Lead sponsor | City Hospitals Sunderland NHS Foundation Trust, Other |
| Collaborators | Takeda Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cerebrovascular Accident, Acute Stroke |
| Intervention type | Drug |
| Interventions | Candesartan |
| Enrollment | 50 |
| Start date | Dec 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Apr 19, 2005 |
| Last update posted | Sep 13, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: